11 – 20 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis
(
- Contribution to journal › Article
-
Mark
A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis
(
- Contribution to journal › Article
- 2016
-
Mark
ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNγ-mediated autophagy and growth restriction of intracellular mycobacteria
(
- Contribution to journal › Article
- 2015
-
Mark
Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count.
(
- Contribution to journal › Article
-
Mark
Impaired CXCR1-dependent oxidative defence in active tuberculosis patients.
(
- Contribution to journal › Article
-
Mark
Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.
(
- Contribution to journal › Article
-
Mark
Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.
(
- Contribution to journal › Article
-
Mark
Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding.
(
- Contribution to journal › Article
- 2014
-
Mark
Intensified Tuberculosis Case-Finding in HIV-Positive Adults Managed at Ethiopian Health Centers: Diagnostic Yield of Xpert MTB/RIF Compared with Smear Microscopy and Liquid Culture.
(
- Contribution to journal › Article
-
Mark
Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres.
(
- Contribution to journal › Article